Description
Dr.Agarwals Eye Hospital Ltd. has listed 1,32,827 new equity shares issued on preferential basis to promoters, effective October 29, 2025, with lock-in until April 29, 2027.
Summary
Dr.Agarwals Eye Hospital Ltd. (Scrip Code: 526783) has listed 1,32,827 new equity shares of Rs. 10/- each issued at a premium of Rs. 5,260/- on a preferential basis to promoters. The shares will commence trading on BSE from October 29, 2025, and are subject to a lock-in period until April 29, 2027.
Key Points
- 1,32,827 equity shares of face value Rs. 10/- each issued
- Issue price: Rs. 5,270/- per share (including premium of Rs. 5,260/-)
- Allotment date: September 26, 2025
- Trading commencement date: October 29, 2025
- Distinction numbers: 4700001 to 4832827
- ISIN: INE934C01018
- Shares rank pari-passu with existing equity shares
- Issued exclusively to promoters on preferential basis
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Trading members must note the listing of new securities effective October 29, 2025
- All 1,32,827 shares are locked-in until April 29, 2027 and cannot be traded during this period
- The new shares carry the same rights and privileges as existing equity shares
Important Dates
- Allotment Date: September 26, 2025
- Trading Commencement: October 29, 2025
- Lock-in Expiry: April 29, 2027
Impact Assessment
This is a routine preferential allotment to promoters with minimal market impact. The shares are subject to an 18-month lock-in period, preventing immediate trading and dilution concerns. The issuance strengthens promoter holding and may be used for business expansion or working capital requirements. No impact on public shareholders’ trading or market liquidity is expected.
Impact Justification
Routine preferential allotment to promoters with standard lock-in period; limited market impact due to promoter-only issuance and lock-in restrictions